Lv21
190 积分 2023-01-29 加入
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
3小时前
已完结
Pericytes in the Optic Nerve Head
17天前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
24天前
已完结
Diabetic macular edema: Upcoming therapies
25天前
已完结
Incidence and multimodal imaging characteristics of macular neovascularisation subtypes in Chinese neovascular age-related macular degeneration patients
26天前
已完结
Claudin 18.2 as a novel therapeutic target
1个月前
已完结
Gastric cancer
1个月前
已完结
Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced gastric or gastro-oesophageal junction cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial
1个月前
已完结
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer
1个月前
已完结
Baseline cluster of differentiation 22 fluorescent intensity correlates with patient outcome after Inotuzumab Ozogamicin treatment
2个月前
已完结
皖公网安备34019202002308
